Integrin signaling in tumor biology: mechanisms of intercellular crosstalk and emerging targeted therapies
PeerJ · 07.05.2025 · 13 · e19328
DOI: 10.7717/peerj.19328 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PeerJ, online erschienen am 07.05.2025. Verfasst von Yifan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Integrins, Neoplasms, Signal Transduction, Cell Communication. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Integrins, a family of transmembrane cell adhesion receptors, mediate intercellular and cell–extracellular matrix crosstalk via outside-in and inside-out signaling pathways. Integrins, categorized into 24 distinct combinations of α and β subunits, exhibit tissue-specific expression and perform unique or overlapping roles in physiological and pathophysiological processes. These roles encompass embryonic angiogenesis, tissue repair, and the modulation of tumor cell angiogenesis, progression, invasion, and metastasis. Notably, integrins are significant contributors to tumor development, offering valuable insights into the potential of integrin-targeted diagnostics and therapeutics. Currently, there are various preclinical and clinical trials aiming to harness integrin antagonists that are safe, efficacious, and exhibit low toxicity. Owing to the functional redundancy across integrin types and the complexity of the mechanisms of integrin-mediated multiple key processes associated with tumor biology, challenges exist that impede advancements in integrin-targeted therapy. Nevertheless, innovative strategies focused on integrin modulation represent significant breakthroughs for improving patient care and promoting comprehensive insights into the underlying mechanisms of tumor biology. This review elucidates the impact of integrins on three distinct cell types in multiple key processes associated with tumor biology and explores the emerging integrin-targeted therapeutic approaches for the treatment of tumors, which will provide ideas for optimal therapeutic approaches in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- The First Clinical College, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- College of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi, China.
Zitieren
APA
Li, Y., Peng, S., Xu, J., Liu, W., & Luo, Q. (2025). Integrin signaling in tumor biology: mechanisms of intercellular crosstalk and emerging targeted therapies. PeerJ, 13, e19328. https://doi.org/10.7717/peerj.19328
Vancouver
Li Y, Peng S, Xu J, Liu W, Luo Q. Integrin signaling in tumor biology: mechanisms of intercellular crosstalk and emerging targeted therapies. PeerJ. 2025;13:e19328. doi:10.7717/peerj.19328
BibTeX
@article{Li2025,
author = {Li, Yifan and Peng, Shantong and Xu, Jiatong and Liu, Wenjie and Luo, Qi},
title = {Integrin signaling in tumor biology: mechanisms of intercellular crosstalk and emerging targeted therapies},
journal = {PeerJ},
year = {2025},
volume = {13},
pages = {e19328},
doi = {10.7717/peerj.19328}
}
EUVIMED